Watchmaker Genomics, Inc. is a U.S. biotechnology company developing enzyme-based tools and workflows for genomics, including next-generation sequencing library preparation and related DNA/RNA analysis applications. It serves research, clinical, and biopharmaceutical users that need high-performance molecular biology and sequencing technologies.
Subscribe to see Watchmaker Genomics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Watchmaker Genomics, Inc. is a biotech company headquartered in United States. It has raised at least $48.3M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $40M in May 2022. Xcout tracks 9 named people at Watchmaker Genomics, Inc., including Trey Foskett (Chief Executive Officer). Xcout recorded 29 job postings from Watchmaker Genomics, Inc. in the last 90 days, naming tools such as Epicor, Salesforce, Microsoft Defender.
3 more named people on record for Watchmaker Genomics, Inc., with roles, board committees and tenure — see the full roster →
At least $48.3M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $40M | 3 named | |
| SEC Form D filing | $8.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 29 job postings from Watchmaker Genomics, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Watchmaker Genomics, Inc.'s hiring signals →
A few of Watchmaker Genomics, Inc.'s closest competitors — see the full list of competitors and alternatives →
DINYA DNA provides a next-generation DNA synthesis platform that utilizes a multi-enzyme process to directly create long and complex double-stranded DNA molecules without requiring traditional oligo assembly. The company serves scientists and researchers by delivering custom DNA sequences with fast turnaround times and minimal complexity limitations.
DNA Script develops enzymatic DNA synthesis technology, offering the SYNTAX platform and associated kits that enable laboratories to produce high-quality oligonucleotides in-house and on-demand. The company serves biotech companies, pharmaceutical firms, contract research organizations, core facilities, and governmental agencies seeking to streamline synthetic biology workflows.
Paragon Genomics is a precision medicine company headquartered in Fremont, California. The company develops and commercializes patented targeted sequencing and breakthrough target enrichment solutions for researchers and clinical applications.
Molecular Loop Biosciences, Inc. is a genomics and targeted sequencing leader headquartered in Woburn, Massachusetts, founded in 2018 to advance molecular biology tools.
New England Biolabs, Inc. (NEB) is an American life sciences company which produces and supplies recombinant and native enzyme reagents for life science research. It also provides products and services supporting genome editing, synthetic biology and next-generation sequencing. NEB also provides free access to research tools such as REBASE, InBASE, and Polbase.
Ultima Genomics is a company headquartered in Fremont, California, with 100-1000 employees. Its mission is to continuously drive the power of genomics, operating in the AI, Biotech/Pharma, and Life Sciences sectors.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.